VSMD — Vasamed Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10KSB | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.07 | 1.39 | 2 | 3.13 | 3.13 |
Cost of Revenue | |||||
Gross Profit | -0.32 | -0.069 | 0.382 | 1.34 | 1.73 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 7.36 | 6.13 | 6.89 | 6.97 | 5.87 |
Operating Profit | -6.3 | -4.74 | -4.88 | -3.84 | -2.73 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.42 | -4.89 | -6.38 | -5.63 | -2.92 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.42 | -4.89 | -6.38 | -5.63 | -2.92 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.42 | -4.89 | -6.38 | -5.63 | -2.92 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -6.42 | -6.85 | -6.48 | -5.63 | -2.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.69 | -1.82 | -1.68 | -0.703 | -0.365 |
Dividends per Share |